A detailed history of Hbk Sorce Advisory LLC transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Hbk Sorce Advisory LLC holds 5,355 shares of MEDP stock, worth $1.66 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
5,355
Previous 5,626 4.82%
Holding current value
$1.66 Million
Previous $2.32 Million 22.96%
% of portfolio
0.07%
Previous 0.09%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$320.58 - $457.29 $86,877 - $123,925
-271 Reduced 4.82%
5,355 $1.79 Million
Q2 2024

Aug 08, 2024

SELL
$372.0 - $424.34 $299,832 - $342,018
-806 Reduced 12.53%
5,626 $2.32 Million
Q1 2024

May 09, 2024

SELL
$284.87 - $413.31 $54,125 - $78,528
-190 Reduced 2.87%
6,432 $2.6 Million
Q4 2023

Jan 25, 2024

SELL
$227.52 - $312.68 $121,950 - $167,596
-536 Reduced 7.49%
6,622 $2.03 Million
Q3 2023

Nov 06, 2023

SELL
$233.98 - $281.67 $17,782 - $21,406
-76 Reduced 1.05%
7,158 $1.73 Million
Q2 2023

Aug 04, 2023

SELL
$187.26 - $240.17 $1.99 Million - $2.55 Million
-10,621 Reduced 59.48%
7,234 $1.74 Million
Q1 2023

Aug 15, 2023

BUY
$174.31 - $239.52 $261,639 - $359,519
1,501 Added 20.75%
8,735 $1.64 Million
Q1 2023

May 15, 2023

SELL
$174.31 - $239.52 $72,338 - $99,400
-415 Reduced 2.27%
17,855 $5.06 Million
Q4 2022

Feb 09, 2023

BUY
$153.06 - $226.57 $1.34 Million - $1.98 Million
8,755 Added 92.01%
18,270 $3.88 Million
Q3 2022

Nov 14, 2022

BUY
$145.13 - $182.49 $464,270 - $583,785
3,199 Added 50.65%
9,515 $1.5 Million
Q2 2022

Aug 15, 2022

SELL
$130.2 - $168.03 $61,193 - $78,974
-470 Reduced 6.93%
6,316 $945,000
Q1 2022

May 13, 2022

BUY
$138.87 - $214.31 $142,619 - $220,096
1,027 Added 17.83%
6,786 $1.11 Million
Q4 2021

Feb 15, 2022

BUY
$182.74 - $227.9 $1.05 Million - $1.31 Million
5,759 New
5,759 $1.25 Million

Others Institutions Holding MEDP

About Medpace Holdings, Inc.


  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $9.66B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track Hbk Sorce Advisory LLC Portfolio

Follow Hbk Sorce Advisory LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hbk Sorce Advisory LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hbk Sorce Advisory LLC with notifications on news.